|
HOUSE OF COMMONS |
|
CHAMBRE DES COMMUNES |
2nd Session, 39th Parliament |
|
2e Session, 39e législature |
|
|
|
NOTICE OF MEETING |
|
AVIS DE CONVOCATION |
|
Standing Committee on Health |
|
Comité permanent de la santé |
|
Meeting No. 25 | | Séance no 25 |
Tuesday, April 29, 2008 | | Le mardi 29 avril 2008 |
11:00 a.m. to 1:00 p.m. | | 11 heures à 13 heures |
Room 253-D, Centre Block |
|
Pièce 253-D, édifice du Centre |
(613-996-4916) |
|
(613-996-4916) |
|
|
|
|
|
|
Orders of the Day |
|
Ordre du jour |
|
|
Post-Market Surveillance of Pharmaceutical Products | | Surveillance post-commercialisation des produits pharmaceutiques |
|
11:00 a.m. to 12:00 p.m. | | 11 heures à 12 heures |
|
Videoconference - Silver Spring | | Vidéoconférence - Silver Spring |
|
Witnesses | | Témoins |
|
U.S. Food and Drug Administration | | U.S. Food and Drug Administration |
|
Gerald Dal Pan, Director Office of Surveillance and Epidermiology, Center for Drug Evaluation and Research | | Gerald Dal Pan, directeur Office of Surveillance and Epidermiology, Center for Drug Evaluation and Research |
|
12:00 p.m. to 1:00 p.m. | | 12 heures à 13 heures |
|
Witnesses | | Témoins |
|
As an individual | | À titre personnel |
|
Jean-Pierre Ménard, Attorney and Specialist in Medical Law Ménard, Martin, Avocats | | Jean-Pierre Ménard, avocat et spécialiste en droit médical Ménard, Martin, Avocats |
|
Brogan Inc. | | Brogan inc. |
|
Tom Brogan, President and Chief Executive Officer | | Tom Brogan, président-directeur général |
|
|
La greffière du Comité |
Carmen DePape ((613) 995-4108) |
Clerk of the Committee |
|
2008/04/22 4:28 p.m. |
|
2008/04/22 16 h 28 |